230 related articles for article (PubMed ID: 36785910)
1. The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies.
Grether A; Ivanovski I; Russo M; Begemann A; Steindl K; Abela L; Papik M; Zweier M; Oneda B; Joset P; Rauch A
Mol Genet Genomic Med; 2023 May; 11(5):e2148. PubMed ID: 36785910
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive prenatal diagnostics: Exome versus genome sequencing.
Miceikaite I; Fagerberg C; Brasch-Andersen C; Torring PM; Kristiansen BS; Hao Q; Sperling L; Ibsen MH; Löser K; Bendsen EA; Ousager LB; Larsen MJ
Prenat Diagn; 2023 Aug; 43(9):1132-1141. PubMed ID: 37355983
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
[TBL] [Abstract][Full Text] [Related]
4. Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing.
Zhou J; Yang Z; Sun J; Liu L; Zhou X; Liu F; Xing Y; Cui S; Xiong S; Liu X; Yang Y; Wei X; Zou G; Wang Z; Wei X; Wang Y; Zhang Y; Yan S; Wu F; Zeng F; Wang J; Duan T; Peng Z; Sun L
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33800913
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
6. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
Front Immunol; 2022; 13():906328. PubMed ID: 35874679
[TBL] [Abstract][Full Text] [Related]
7. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
Linthorst GE; Hollak CEM
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
[TBL] [Abstract][Full Text] [Related]
8. Using the Sankey diagram to visualize article features on the topics of whole-exome sequencing (WES) and whole-genome sequencing (WGS) since 2012: Bibliometric analysis.
Li MJ; Chien TW; Liao KW; Lai FJ
Medicine (Baltimore); 2022 Sep; 101(38):e30682. PubMed ID: 36197161
[TBL] [Abstract][Full Text] [Related]
9. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
[TBL] [Abstract][Full Text] [Related]
11. Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses.
Kvapilova K; Misenko P; Radvanszky J; Brzon O; Budis J; Gazdarica J; Pos O; Korabecna M; Kasny M; Szemes T; Kvapil P; Paces J; Kozmik Z
BMC Genomics; 2024 Feb; 25(1):187. PubMed ID: 38365587
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies.
Palmer EE; Sachdev R; Macintosh R; Melo US; Mundlos S; Righetti S; Kandula T; Minoche AE; Puttick C; Gayevskiy V; Hesson L; Idrisoglu S; Shoubridge C; Thai MHN; Davis RL; Drew AP; Sampaio H; Andrews PI; Lawson J; Cardamone M; Mowat D; Colley A; Kummerfeld S; Dinger ME; Cowley MJ; Roscioli T; Bye A; Kirk E
Neurology; 2021 Mar; 96(13):e1770-e1782. PubMed ID: 33568551
[TBL] [Abstract][Full Text] [Related]
13. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
[TBL] [Abstract][Full Text] [Related]
14. Novel ITPA variants identified by whole genome sequencing and RNA sequencing.
Omichi N; Kishita Y; Nakama M; Sasai H; Terazawa A; Kobayashi E; Fushimi T; Sugiyama Y; Ichimoto K; Nitta KR; Yatsuka Y; Ohtake A; Murayama K; Okazaki Y
J Hum Genet; 2023 Sep; 68(9):649-652. PubMed ID: 37246162
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Exome and Genome Sequencing Technologies for the Complete Capture of Protein-Coding Regions.
Lelieveld SH; Spielmann M; Mundlos S; Veltman JA; Gilissen C
Hum Mutat; 2015 Aug; 36(8):815-22. PubMed ID: 25973577
[TBL] [Abstract][Full Text] [Related]
16. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
[TBL] [Abstract][Full Text] [Related]
17. Clinical RNA sequencing confirms compound heterozygous intronic variants in RYR1 in a patient with congenital myopathy, respiratory failure, neonatal brain hemorrhage, and d-transposition of the great arteries.
Shillington A; Zea Vera A; Perry T; Hopkin R; Thomas C; Cooper D; Suhrie K
Mol Genet Genomic Med; 2021 Oct; 9(10):e1804. PubMed ID: 34528764
[TBL] [Abstract][Full Text] [Related]
18. Robust identification of deletions in exome and genome sequence data based on clustering of Mendelian errors.
Manheimer KB; Patel N; Richter F; Gorham J; Tai AC; Homsy J; Boskovski MT; Parfenov M; Goldmuntz E; Chung WK; Brueckner M; Tristani-Firouzi M; Srivastava D; Seidman JG; Seidman CE; Gelb BD; Sharp AJ
Hum Mutat; 2018 Jun; 39(6):870-881. PubMed ID: 29527824
[TBL] [Abstract][Full Text] [Related]
19. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
[TBL] [Abstract][Full Text] [Related]
20. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
Schwarze K; Buchanan J; Taylor JC; Wordsworth S
Genet Med; 2018 Oct; 20(10):1122-1130. PubMed ID: 29446766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
